Table 2 of Khan, Mol Vis 2010; 16:2146-2152.
Genotype | Group | Controls (n=162) | Patients (n=165) | p (χ2) |
---|---|---|---|---|
T0 | Total | 16 (10%) | 39 (24%) | <0.05 (11.06) |
T1 | 146 (90%) | 126 (76%) | ||
M0 | Total | 58 (36%) | 85 (52%) | <0.05 (8.20) |
M1 | 104 (64%) | 80 (48%) | ||
Genotype | Controls (n=77) | Patients (n=77) | p (χ2) | |
T0 | Females | 1 (1%) | 20 (26%) | <0.05 (19.90) |
T1 | 76 (99%) | 57 (74%) | ||
M0 | Females | 16 (21%) | 42 (55%) | <0.05 (18.70) |
M1 | 61 (79%) | 35 (45%) | ||
Genotype | Controls (n=85) | Patients (n=88) | p (χ2) | |
T0 | Males | 15 (18%) | 19 (22%) | >0.05(0.43) |
T1 | 70 (82%) | 69 (78%) | ||
M0 | Males | 42 (49%) | 43 (49%) | >0.05(0.01) |
M1 | 43 (51%) | 45 (51%) |